Effect of levocarnitine administration in patients with chronic liver disease

L-carnitine administration was reported to improve sarcopenia in patients with cirrhosis. However, the amount of evidence from previous studies is not sufficient. The present study aimed to clarify the effect of levocarnitine (L-carnitine) administration on body composition in patients with chronic...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Exp Ther Med
Auteurs principaux: Ohashi, Kazuki, Ishikawa, Toru, Hoshii, Asami, Hokari, Tamaki, Suzuki, Mitsuyuki, Noguchi, Hirohito, Hirosawa, Hiroshi, Koyama, Fujiko, Kobayashi, Miki, Hirosawa, Shiori, Sugiyama, Kaede, Mitobe, Yuta, Yoshida, Toshiaki
Format: Artigo
Langue:Inglês
Publié: D.A. Spandidos 2020
Sujets:
Articles
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7507016/
https://ncbi.nlm.nih.gov/pubmed/32973943
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/etm.2020.9222
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires